The Long-term Prognostic Performance of Ki-67 in Primary Operable Breast Cancer and Evaluation of Its Optimal Cutoff Value. Issue 3 (March 2016)

• Record Type: Journal Article
• Authors: Cho, Uiju; Kim, Hee Eun; Oh, Woo Jin; Yeo, Min-Kyung; Song, Byung Joo; Lee, Ahwon
• Is Part Of: Applied immunohistochemistry & molecular morphology. Volume 24:Issue 3(2016)
• Publication Date: 2016-03
• Subjects: antigen Ki-67 -- breast cancer -- prognosis -- survival analysis; Diagnostic immunohistochemistry -- Periodicals; Immunohistochemistry -- Periodicals; Cells -- Morphology -- Periodicals; Molecular diagnosis -- Periodicals; 616.079
• DOI: 10.1097/PAI.0000000000000164
• Languages: English
• ISSNs: 1541-2016

Abstract

Abstract : Markers of proliferation are considered to have prognostic importance in breast cancer (BC). The Ki-67 index has been reported as a prognostic factor, but standardized cutoff values and counting methods are not yet established. We assayed the Ki-67 labeling index (LI) of 589 consecutive operable BC patients who underwent surgical resection. Ki-67 immunostaining was performed, and the LI was manually counted using an image processing program. We also compared the manual cell count (MCC) of Ki-67 to the whole-section eyeballed estimate count (EEC). Univariate survival analysis showed statistically significant differences in long-term BC-specific survival in the following factors: tumor size, histologic grade, nuclear grade, lymph node metastasis stage, estrogen receptor, progesterone receptor, human epidermal growth factor-2 (HER2) status, and intrinsic type ( P <0.05). The MCC and EEC Ki-67 evaluations were statistically well correlated (Pearson correlation=0.683, P <0.001). Their agreement rate was highest at a 20% cutoff (κ-coefficient=0.464). With cutoff values of 14% and 20%, high Ki-67 LI was associated with poor BC-specific survival ( P =0.028 and 0.012, respectively), and a 20% cutoff had a higher hazard ratio. High Ki-67 LI with a 20% cutoff was also associated with poor survival in the hormone receptor–positive and lymph node–positive subgroups ( P =0.015 and 0.016, respectively). In conclusion, Ki-67 LI had prognostic significance, especially in hormone receptor–positive and lymph node–positive BC patients. EEC was relatively reliable counting method with a higher cutoff value. We suggest that the 20% cutoff value be the preferable value in clinical practice.